首页 文献索引 SCI期刊 AI助手
首页 正文

Journal of geriatric oncology. 2024 Mar;15(2):101640. doi: 10.1016/j.jgo.2023.101640 Q32.72025

Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma

西米普利姆早期中断用于治疗晚期皮肤鳞状细胞癌患者的疗效 翻译改进

Andrea Boutros  1, Elena Croce  2, Enrica Teresa Tanda  3, Federica Cecchi  3, Luca Arecco  4, Carlo Genova  4, Ilaria Baldelli  5, Matteo Lambertini  4, Edoardo Raposio  5, Lucia Del Mastro  4, Francesco Spagnolo  6

作者单位 +展开

作者单位

  • 1 Skin Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy. Electronic address: boutros.andrea@gmail.com.
  • 2 Skin Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy.
  • 3 Skin Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • 4 Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genoa, Genova, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • 5 Department of Surgical Sciences and Integrated Diagnostics (DISC), Plastic Surgery Division, University of Genoa, Genova, Italy.
  • 6 Skin Cancer Unit, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Surgical Sciences and Integrated Diagnostics (DISC), Plastic Surgery Division, University of Genoa, Genova, Italy.

    • DOI: 10.1016/j.jgo.2023.101640 PMID: 37798175

    摘要 中英对照阅读

    Copyright © Journal of geriatric oncology. 中文内容为AI机器翻译，仅供参考！

    相关内容

    期刊名：Journal of geriatric oncology

    缩写：J GERIATR ONCOL

    ISSN：1879-4068

    e-ISSN：1879-4076

    IF/分区：2.7/Q3

    文章目录 更多期刊信息

    全文链接
    官方链接
    PMC全文
    引文链接
    复制
    已复制！
    推荐内容
    Early discontinuation of cemiplimab in patients with advanced cutaneous squamous cell carcinoma